A novel antiviral formulation inhibits SARS-CoV-2 infection of human bronchial epithelium

MLA

Kevin Purves, et al. A Novel Antiviral Formulation Inhibits SARS-CoV-2 Infection of Human Bronchial Epithelium. Oct. 2022. EBSCOhost, https://doi.org/10.1101/2022.10.05.510928.

APA

Kevin Purves, Ruth Haverty, Tiina O’Neill, David Folan, Sophie O’Reilly, Alan W. Baird, Dimitri Scholz, Patrick W Mallon, Virginie Gautier, Michael Folan, & Nicola F Fletcher. (2022). A novel antiviral formulation inhibits SARS-CoV-2 infection of human bronchial epithelium. https://doi.org/10.1101/2022.10.05.510928

Chicago

Kevin Purves, Ruth Haverty, Tiina O’Neill, David Folan, Sophie O’Reilly, Alan W. Baird, Dimitri Scholz, et al. 2022. “A Novel Antiviral Formulation Inhibits SARS-CoV-2 Infection of Human Bronchial Epithelium,” October. doi:10.1101/2022.10.05.510928.